Skip to main content

Advertisement

Table 1 Comparison of bone marrow aspiration analyses before and after therapy

From: A novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case

Cell type Cell count (%)
Reference
(Mean ± sem)
Before therapy After therapy
Myeloblast 0.64 ± 0.33 1.5 0
Promyelocyte 1.57 ± 0.60 1.0 0
Neutrophil
 N.myelocyte 6.49 ± 2.04 7.0 1
 N.metamyelocyte 7.90 ± 1.97 6.5 1
 N. band 23.72 ± 3.50 33.0 20
 Neutrophil 9.44 ± 2.92 28.0 45
Eosinophil 0.86 ± 0.61 10.5 7
Basophil 0.03 ± 0.05 3.5 0
Lymphocyte 22.78 ± 7.04 4.0 20
Monocyte 3.00 ± 0.88 0 3